Antipsychotic polypharmacy
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
... in free-text fields. The process described here, may be adapted to extract an array of factors, which may predict antipsychotic polypharmacy and/or confound associa- tions between APP and mental or physical ...
7
A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome
... oral antipsychotic polypharmacy- associated NMS could not be ruled out in this case with- out definite MH diagnosis made by muscular ...most antipsychotic drugs may cause ...
5
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross sectional study
... antipsychotic polypharmacy, compared with monother- apy, may be independently associated with an increased risk of having pre-metabolic syndrome, even after adjusting for patients’ lifestyle ...of ...
6
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
... dose antipsychotic polypharmacy (the SCAP method), in which the initial total dose of all antipsychotic drugs is calculated and converted to a chlorpromazine equivalent (expressed as milligrams of ...
6
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
... of antipsychotic polyp- harmacy among the 3 studied atypical antipsychotics, fol- lowed by risperidone and olanzapine, thus increasing the average daily and annual antipsychotic costs of treating patients ...
10
Determination of Changes in Blood Biomarker Levels in Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients With Long-term Schizophrenia
... chizophrenia is a psychiatric disorder with a wide range of biological and clinical manifestations. It affects 1% of the popu- lation; however, its exact causative factor is not completely known [1]. More than 50% of ...
8
Antipsychotic polypharmacy in a regional health service: a population based study
... Although antipsychotic polypharmacy is widely used in our healthcare setting, it appears not to follow the avail- able clinical practice guidelines indicating the use of using antipsychotic ...
9
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
... another antipsychotic, aripiprazole protects against the risk of metabolic ...an antipsychotic drug’s mechanism or receptor binding pro- file and metabolic syndrome is thought to be very com- plex, and ...
13
OBSERVATIONAL STUDY TO EVALUATE PRESCRIPTION PATTERNS IN SCHIZOPHRENIA INPATIENT DEPARTMENT OF PSYCHIATRY UNIT
... of antipsychotic drugs in patients with psychotic disorders including schizophrenia have revealed widely variable rates (13–90%) of antipsychotic polypharmacy, defined as the use of more than one ...
8
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
... sponsor's antipsychotic medication (in this case, ...using antipsychotic polypharmacy to be higher for quetiapine compared to risperidone (odds ratio ...for antipsychotic polypharmacy ...
11
Role of aripiprazole in treatment-resistant schizophrenia
... of antipsychotic polypharmacy in general, no confident recommendations can be made and careful clinical appraisal of the risk-benefit ratio of all options is ...
10
More than Half of Patients with Schizophrenia Are Receiving Polypharmacy and Co Prescription of Anxiolytics in Pakistan —Findings from Research on Asian Prescription Pattern in 2016
... psychotic polypharmacy and a higher rate of co-prescription of mood stabi- lizers and anxiolytics when compared with participants from other South Asian countries (India and ...prescribed antipsychotic ...
13
Conformance to schizophrenia treatment guidelines in North West Bank, Palestine: focus on antipsychotic dosing and polytherapy
... that antipsychotic combination was not associated with better clinical ...that antipsychotic polypharmacy (APP) led to greater worsening on verbal memory compared to anti- psychotic monotherapy (APM) ...
8
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
... However, polypharmacy has been associated with excessive total antipsychotic doses, which may increase dose-related side effects, the risk for drug interactions, and complicated dosing regimens that may ...
9
Antipsychotic Medication and Risk of QTc Prolongation: Focus on Multiple Medication and Role of Cytochrome P450 Isoforms
... pattern, antipsychotic doses and cytochrome P450 (CYP) mediation, us- ing large database describing the antipsychotic treatment of patients with schizophrenia in ...the antipsychotic CPZ-equivalent ...
10
Adverse drug reactions experienced by out patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi
... Weight gain and sedation were second and third most commonly experienced ADRs respectively (Figs. 1, 2). Sedation caused mainly by chlorpromazine was also the most common male ADR reported in Guntur, Andhra Pradesh [33], ...
6
Attempting to discontinue antipsychotic medication: withdrawal methods, relapse and success
... If you have made more than one attempt to stop taking antipsychotic medication, please think about your most recent attempt when answering the following questions. If your most recent discontinuation experience ...
11
Approaches to improve adherence to pharmacotherapy in patients with schizophrenia
... include antipsychotic drug class and formulation, patient-specific factors, and family/social support ...typical antipsychotic or with a long-acting injectable versus an oral ...
14
POLYPHARMACY IN ELDERLY PATIENTS AND THEIR PROBLEMS
... process will lower physiological functions, for example; decreased bone density, osteoarthritis, and suffering cataract lens, while the diseases associated with old age, but does not occur in all people (aging ...
6
Non adherence to antipsychotic medication, relapse and rehospitalisation in recent onset schizophrenia
... included patients moved to another region and 6 patients received limited psychosocial treatment and follow-up. However, it was possible to reach all patients for evalua- tions. Demographic and clinical characteristics ...
7